Nur Kebapçı

894 total citations
36 papers, 563 citations indexed

About

Nur Kebapçı is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Nur Kebapçı has authored 36 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Nur Kebapçı's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Parathyroid Disorders and Treatments (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Nur Kebapçı is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Parathyroid Disorders and Treatments (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Nur Kebapçı collaborates with scholars based in Türkiye, United States and Norway. Nur Kebapçı's co-authors include Belgi̇n Efe, Canan Demirüstü, Emre Entok, Sema Uslu, Mahmut Kebapçı, Baki Adapınar, Cengiz Bal, A. Yenilmez, Ayşen Akalın and Özkan Alataş and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Atherosclerosis.

In The Last Decade

Nur Kebapçı

33 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nur Kebapçı Türkiye 12 204 141 135 103 90 36 563
Ayşe Kubat Üzüm Türkiye 13 160 0.8× 107 0.8× 63 0.5× 47 0.5× 13 0.1× 59 474
Rebecca I. Schneider United States 13 100 0.5× 130 0.9× 44 0.3× 14 0.1× 36 0.4× 15 596
Robert Kozłowski Poland 12 147 0.7× 81 0.6× 56 0.4× 14 0.1× 380 4.2× 26 600
C. Vandepol United States 13 132 0.6× 136 1.0× 100 0.7× 25 0.2× 12 0.1× 20 782
Arianne van Koppen Netherlands 13 44 0.2× 155 1.1× 101 0.7× 71 0.7× 9 0.1× 23 639
Ercan Tuncel Türkiye 17 276 1.4× 241 1.7× 100 0.7× 24 0.2× 6 0.1× 41 772
K. K. Pun Hong Kong 13 240 1.2× 153 1.1× 62 0.5× 65 0.6× 7 0.1× 41 785
Hulusi Atmaca Türkiye 14 300 1.5× 161 1.1× 74 0.5× 20 0.2× 5 0.1× 39 664
Katsumi Goji Japan 14 294 1.4× 88 0.6× 13 0.1× 34 0.3× 30 0.3× 25 594
Masumi Nozawa Japan 16 222 1.1× 479 3.4× 52 0.4× 138 1.3× 10 0.1× 51 864

Countries citing papers authored by Nur Kebapçı

Since Specialization
Citations

This map shows the geographic impact of Nur Kebapçı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nur Kebapçı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nur Kebapçı more than expected).

Fields of papers citing papers by Nur Kebapçı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nur Kebapçı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nur Kebapçı. The network helps show where Nur Kebapçı may publish in the future.

Co-authorship network of co-authors of Nur Kebapçı

This figure shows the co-authorship network connecting the top 25 collaborators of Nur Kebapçı. A scholar is included among the top collaborators of Nur Kebapçı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nur Kebapçı. Nur Kebapçı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kebapçı, Nur, et al.. (2025). Prognostic significance of Lin28A protein expression in papillary thyroid carcinoma. Indian Journal of Pathology and Microbiology. 68(3). 486–491.
2.
3.
Bayram, Fahrı, Alper Sönmez, Cem Haymana, et al.. (2020). Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study). Lipids in Health and Disease. 19(1). 237–237. 8 indexed citations
4.
Onbaşı, Kevser, et al.. (2016). Hypoglobulinemia and Nonsecretory Myeloma as a Rare Cause of Osteoporosis in a Young Man. SHILAP Revista de lepidopterología. 20(2). 61–62. 1 indexed citations
5.
Baş, Demet Funda, Atilla Özcan Özdemi̇r, Ertuğrul Çolak, & Nur Kebapçı. (2016). Higher Insulin Resistance Level is Associated with Worse Clinical Response in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis. Translational Stroke Research. 7(3). 167–171. 23 indexed citations
6.
Aydoğan, Berna İmge, Mazhar Müslüm Tuna, Melek Eda Ertörer, et al.. (2016). Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey. Journal of Clinical Research in Pediatric Endocrinology. 8(1). 13–20. 8 indexed citations
7.
Çevik, Arif Alper, et al.. (2014). Low perfusion index affects the difference in glucose level between capillary and venous blood. Therapeutics and Clinical Risk Management. 10. 985–985. 3 indexed citations
8.
Efe, Belgi̇n, et al.. (2014). Investigation on Carbohydrate Counting Method in Type 1 Diabetic Patients. BioMed Research International. 2014. 1–8. 9 indexed citations
9.
Kebapçı, Nur, et al.. (2013). Metabolic Syndrome Is a Risk Factor for the Development of Chronic Renal Disease. Renal Failure. 35(4). 460–465. 4 indexed citations
10.
Tanrıverdi, Fatih, Hatice Sebila Dökmetaş, Nur Kebapçı, et al.. (2013). Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database. Endocrine. 47(1). 198–205. 54 indexed citations
11.
Uslu, Sema, et al.. (2012). Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Experimental and Therapeutic Medicine. 4(1). 113–120. 71 indexed citations
12.
Kebapçı, Nur, et al.. (2010). Primary hyperparathyroidism at pregnancy. 22. 1 indexed citations
13.
Kebapçı, Nur, et al.. (2009). Dwarfism and female extenal genitalia due to congenital partial hypopituitarism in a 46XY Seckel syndrome with microcephaly and multiple skeletal deformities. 20. 1 indexed citations
14.
Kebapçı, Nur, et al.. (2009). Possible effects of IGF-1 and IGF-3 in the development of growth failure, type 2 diabetes mellitus and severe insulin resistance in a case of Seckel syndrome. 20. 2 indexed citations
15.
Yenilmez, A., et al.. (2008). Morbidity after urodynamic study in diabetic patients. Acta Diabetologica. 46(3). 197–202. 5 indexed citations
16.
Akalın, Ayşen, et al.. (2006). A case of primary pigmented micronodular hyperplasia as a cause of Cushing syndrome. 11. 1 indexed citations
17.
Uslu, Sema, Belgi̇n Efe, Özkan Alataş, et al.. (2005). Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients. Journal of Nephrology. 18(5). 559–567. 60 indexed citations
18.
Değirmenci, İrfan, Nur Kebapçı, Belgi̇n Efe, et al.. (2005). Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. International Journal of Clinical Practice. 59(10). 1137–1142. 36 indexed citations
19.
Kebapçı, Mahmut, Baki Adapınar, Tamer Kaya, & Nur Kebapçı. (2004). [Mesenteric panniculitis of the colon: barium enema, US, CT, and MRI findings (case report)].. PubMed. 10(4). 284–8. 2 indexed citations
20.
Kebapçı, Mahmut, Emre Entok, Nur Kebapçı, & Baki Adapınar. (2004). Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. Journal of Endocrinological Investigation. 27(1). 24–30. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşe Kubat Üzüm Breakdown of academic impact, for papers by Rebecca I. Schneider Breakdown of academic impact, for papers by Robert Kozłowski Breakdown of academic impact, for papers by C. Vandepol Breakdown of academic impact, for papers by Arianne van Koppen Breakdown of academic impact, for papers by Ercan Tuncel Breakdown of academic impact, for papers by K. K. Pun Breakdown of academic impact, for papers by Hulusi Atmaca Breakdown of academic impact, for papers by Katsumi Goji Breakdown of academic impact, for papers by Masumi Nozawa
Rankless by CCL
2026